
Artgen
web2Artgen Biotech is a Russian biotechnology company that develops biomedical treatments, diagnost...
About
Artgen Biotech is a Russian biotechnology company that develops biomedical treatments, diagnostic technologies, medical devices, and related healthcare services through a portfolio of research and operating businesses. Its development areas include vaccines, antibodies, gene therapies, and regenerative medicine technologies, with projects at differing stages of research and clinical use. Artgen also works in medical genetics, biological sample storage, and cell-based services through businesses in its ecosystem. The group invests in and helps commercialize healthcare technologies rather than operating solely as a single-product drug developer. Formerly known as the Human Stem Cell Institute, its shares trade on the Moscow Exchange under ABIO.
Explore this sector
Exchange listings
Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.
Artgen profile.
Expert coverage
No published expert evaluations are available for this project yet.
Orbitrum Academy